Compass Therapeutics, Inc.
$2.40
-0.12 (-4.76%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +23.7%
- 3 Months
- +0.8%
- YTD
- -55.3%
- 1 Year
- -26.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 89.5%
- Largest decline max drawdown, since Aug 2025
- -75.0%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.30
Own CMPX?
See how CMPX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.